Literature DB >> 11259157

Population genetics of factor V Leiden in Europe.

G Lucotte1, G Mercier.   

Abstract

We have analyzed 5971 control individuals originating from 26 geographically defined populations in Europe and neighboring countries for the presence of factor V Leiden, an important genetic risk factor in venous thromboembolism. The mean frequency of the mutation in the populations studied is 0.027%, with a peak value incidence of more than 12% in Cyprus; the mutation is absent in Inuits and is at low incidence in French Basques. A west to east increasing cline of allele factor V Leiden prevalence (r = 0.479, p < 0.02) was observed in Europe, together with a decreasing south to north cline (r = -0.801, p < 0.001) of these values-but in this last situation only when southwest populations are excluded from the analysis. Based on these findings, an interpretation is proposed of the history of factor V Leiden expansion in Europe during the Neolithic period, from a probable Anatolian center of origin in Turkey. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259157     DOI: 10.1006/bcmd.2001.0388

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  14 in total

1.  Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Hadi Mozafari; Hadi Kharrazi; Mansour Rezaei; Ronald L Nagel
Journal:  J Thromb Thrombolysis       Date:  2007-08-14       Impact factor: 2.300

2.  The distribution of Factor V Leiden mutation.

Authors:  Aydan Eroğlu
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

3.  G2691A and C2491T mutations of factor V gene and pre-disposition to myocardial infarction in Morocco.

Authors:  Wiam Hmimech; Brehima Diakite; Hind Hassani Idrissi; Khalil Hamzi; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Biomed Rep       Date:  2016-09-30

4.  Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan.

Authors:  R Dajani; A Arafat; N Hakooz; Z Al-Abbadi; Al-Motassem Yousef; M El Khateeb; F Quadan
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

5.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

6.  Evolving methods for single nucleotide polymorphism detection: Factor V Leiden mutation detection.

Authors:  Herin Oh; Cassandra L Smith
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 7.  Etiology and consequences of thrombosis in abdominal vessels.

Authors:  Yusuf Bayraktar; Ozgur Harmanci
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

8.  Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.

Authors:  Rana Dajani; Raja Fatahallah; Abdelrahman Dajani; Mohammad Al-Shboul; Yousef Khader
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

9.  Risk factors of thrombosis in abdominal veins.

Authors:  Amit-Kumar Dutta; Ashok Chacko; Biju George; Joseph Anjilivelil Joseph; Sukesh Chandran Nair; Vikram Mathews
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

10.  The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population.

Authors:  M Ekim; H Ekim; Y K Yılmaz
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.